SINGAPORE,Jan. 24,2025 --Following the annual meeting of the Rogers International Commodity Index (RICI®) Committee,Jim Rogers and Beeland Interests,Inc. announce no adjustments to the weights or components comprising the RICI. This outcome reaffirms the founding premise that for the sake of transparency,consistency and stability,composition changes to theRICI be infrequent.
The RICI represents the value of a compendium (or "basket") of globally traded commodities employed in the global economy (38 commodity futures contracts),ranging from agricultural and energy products to metals and minerals. The RICI and its various sub-indexes are used by many investment banks and investors throughout the world.
A copy of the current RICI Handbook may be downloaded free of charge at the following Internet link: https://www.beelandinterests.com/#rici-handbook
Jim Rogers,an advocate of commodities-based investing,created the RICI in 1997 and 1998 and is the CEO of Beeland Interests,Inc.,the owner of the Index. The RICI Committee,currently chaired by Jim Rogers,determines the Index components and weights.Jim Rogers also is the author of Investment Biker,Adventure Capitalist,Hot Commodities,A Bull In China,A Gift to My Children and Street Smarts – Adventures on the Road and in the Markets.
"Jim Rogers","James Beeland Rogers,Jr.",and "Rogers" are trademarks and service marks of,and "Rogers International Commodity Index" and "RICI" are registered trademarks and service marks of,Beeland Interests,which are used subject to license. The personal names and likeness of Jim Rogers/JamesBeeland Rogers,Jr. are owned and licensed by James Beeland Rogers,Jr.
Related Links
http://www.beelandinterests.com
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors